Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Board Meeting intimation for un-audited (Standalone and Consolidated) financial results for the quarter and half year ended on 30th September, 2026.

Ref: Akums/Exchange/2026-27/55 October 28, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 544222 Symbol: AKUMS Sub: Intimation of Board Meeting Respected Sir/Madam, This is to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, meeting of the Board of Directors of Akums Drugs and Pharmaceuticals Limited (“the Company”) is scheduled to be held on Monday, 2nd November, 2026, inter alia to consider and approve the un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended on September 30, 2026. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Trading Window for trading in the securities of the Company which is already closed shall open after 48 hours of the declaration of the above-mentioned un-audited financial results. A copy of this disclosure is being updated on the website of the Company at www.akums.in This is for your kind information and records. Thanking You For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer